Delivery Order SPE2DB22D2211-SPE2DB25FRYUH
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,193.52, is a Firm Fixed Price Delivery Order for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used for diabetes management. The contract has an ultimate completion date of May 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices to the Defense Logistics Agency (DLA), a defense agency. The $1,816.31 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 16, 2025, with a completion date of May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,267.60 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 30, 2025. This award is not associated with a set-aside program and is likely part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,881.39 firm-fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract has a period of performance through May 15, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.52 firm-fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract has an ultimate completion date of March 26, 2025 and was awarded on March 25, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen also...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,387.04 Firm Fixed Price Delivery Order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $2,152.33 for OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a...
This federal contract award is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,790.28 and is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price, non-set-aside award with a completion date of May 12, 2025. Amerisourcebergen Drug Corp is a critical supplier of medical...
This federal contract award, valued at $3,706.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of March 18, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, identified as SPE2DB22D3009|SPE2DB25FAW12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,134.26 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices, with a performance period through April 29, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...